Pomanda estimates the enterprise value of SAGARD HEALTHCARE ROYALTY PARTNERS DESIGNATED ACTIVITY COMPANY at €20.1m based on a Turnover of €24m and 0.84x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of SAGARD HEALTHCARE ROYALTY PARTNERS DESIGNATED ACTIVITY COMPANY at €0 based on an EBITDA of €-2.8k and a 3.21x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of SAGARD HEALTHCARE ROYALTY PARTNERS DESIGNATED ACTIVITY COMPANY at €7.1k based on Net Assets of €3k and 2.38x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Sagard Healthcare Royalty Partners Designated Activity Company is a live company, 662881 with a Companies House number of IE644718. It operates in the credit granting by non-deposit taking finance houses and other specialist consumer credit grantors sector, SIC Code 64921. Founded in February 2019, it's largest shareholder is
maplesfs trustees ireland limited
with a 100% stake. Sagard Healthcare Royalty Partners Designated Activity Company is a young,
large sized company, Pomanda has estimated its turnover at
€24m with
rapid
growth in recent years.
Sagard Healthcare Royalty Partners Designated Activity Company Health Check
Pomanda's financial health check has awarded Sagard Healthcare Royalty Partners Designated Activity Company a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 3 areas for improvement. Company Health Check FAQs
Health Rating2.5out of 5
2 Strong
4 Regular
3 Weak
Size
annual sales of €24m, make it in line with the average company (€21.1m)
€24m - Sagard Healthcare Royalty Partners Designated Activity Company
€21.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 142%, show it is growing at a faster rate (23.3%)
142% - Sagard Healthcare Royalty Partners Designated Activity Company
23.3% - Industry AVG
Production
with a gross margin of 0.4%, this company has a higher cost of product (15.8%)
0.4% - Sagard Healthcare Royalty Partners Designated Activity Company
15.8% - Industry AVG
Profitability
an operating margin of 0% make it less profitable than the average company (10.2%)
0% - Sagard Healthcare Royalty Partners Designated Activity Company
10.2% - Industry AVG
Employees
with 54 employees, this is above the industry average (12)
54 - Sagard Healthcare Royalty Partners Designated Activity Company
12 - Industry AVG
Pay Structure
on an average salary of €66.5k, the company has an equivalent pay structure (€66.5k)
€66.5k - Sagard Healthcare Royalty Partners Designated Activity Company
€66.5k - Industry AVG
Efficiency
resulting in sales per employee of €444.8k, this is equally as efficient (€446.1k)
€444.8k - Sagard Healthcare Royalty Partners Designated Activity Company
€446.1k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Sagard Healthcare Royalty Partners Designated Activity Company
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Sagard Healthcare Royalty Partners Designated Activity Company
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Sagard Healthcare Royalty Partners Designated Activity Company
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 0 weeks, this is less cash available to meet short term requirements (5 weeks)
0 weeks - Sagard Healthcare Royalty Partners Designated Activity Company
5 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 100%, this is a similar level of debt than the average (100%)
100% - Sagard Healthcare Royalty Partners Designated Activity Company
100% - Industry AVG
SAGARD HEALTHCARE ROYALTY PARTNERS DESIGNATED ACTIVITY COMPANY financials
EXPORT
Sagard Healthcare Royalty Partners Designated Activity Company's latest turnover from December 2024 is €24 million and the company has net assets of €3 thousand. According to their latest financial statements, we estimate that Sagard Healthcare Royalty Partners Designated Activity Company has 54 employees and maintains cash reserves of €282.9 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Turnover
24,017,535
29,626,506
2,906,569
1,694,084
3,739,764
1,459,478
Other Income Or Grants
Cost Of Sales
23,920,185
29,491,222
2,810,588
1,598,305
3,625,630
1,110,004
Gross Profit
97,350
135,284
95,981
95,779
114,134
349,474
Admin Expenses
100,135
-6,572,040
-7,831,572
-1,703,221
-739,337
352,230
Operating Profit
-2,785
6,707,324
7,927,553
1,799,000
853,471
-2,756
Interest Payable
974,588
Interest Receivable
Pre-Tax Profit
952
1,013
1,003
934
Tax
-238
-253
-251
-234
Profit After Tax
714
760
752
700
Dividends Paid
Retained Profit
714
760
752
700
Employee Costs
3,593,405
4,501,325
586,300
384,826
855,714
442,734
Number Of Employees
54
69
9
6
15
8
EBITDA*
-2,785
6,707,324
7,927,553
1,799,000
853,471
-2,756
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Tangible Assets
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
Stock & work in progress
Trade Debtors
Group Debtors
Misc Debtors
30,251
1
Cash
282,944
42,034
6,717
6,628
88,583
965,501
misc current assets
207,660,814
245,412,775
162,633,216
29,593,339
28,112,018
26,813,333
total current assets
207,974,010
245,454,810
162,639,934
29,599,967
28,200,603
27,778,836
total assets
207,974,010
245,454,810
162,639,934
29,599,967
28,200,603
27,778,836
Bank overdraft
Bank loan
Trade Creditors
Group/Directors Accounts
1
1
other short term finances
162,592,623
29,571,878
27,999,923
hp & lease commitments
other current liabilities
207,971,029
245,452,542
45,766
27,305
199,835
27,778,133
total current liabilities
207,971,030
245,452,544
162,638,389
29,599,184
28,199,759
27,778,135
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
207,971,030
245,452,544
162,638,389
29,599,184
28,199,759
27,778,135
net assets
2,980
2,266
1,545
783
844
701
total shareholders funds
2,980
2,266
1,545
783
844
701
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Operating Activities
Operating Profit
-2,785
6,707,324
7,927,553
1,799,000
853,471
-2,756
Depreciation
Amortisation
Tax
-238
-253
-251
-234
Stock
Debtors
30,251
-1
1
Creditors
Accruals and Deferred Income
-37,481,513
245,406,776
18,461
-172,530
-27,578,298
27,778,133
Deferred Taxes & Provisions
Cash flow from operations
-37,514,787
252,113,847
7,945,763
1,626,471
-26,724,828
27,775,143
Investing Activities
capital expenditure
Change in Investments
cash flow from investments
Financing Activities
Bank loans
Group/Directors Accounts
1
-1
1
Other Short Term Loans
-162,592,623
133,020,745
1,571,955
27,999,923
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
-39
10
-60
143
1
interest
-974,588
cash flow from financing
-162,592,661
133,020,755
1,571,895
28,000,065
-974,586
cash and cash equivalents
cash
240,910
35,317
89
-81,955
-876,918
965,501
overdraft
change in cash
240,910
35,317
89
-81,955
-876,918
965,501
sagard healthcare royalty partners designated activity company Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for sagard healthcare royalty partners designated activity company. Get real-time insights into sagard healthcare royalty partners designated activity company's credit score, group structure and payment trends.
Sagard Healthcare Royalty Partners Designated Activity Company Competitor Analysis
Perform a competitor analysis for sagard healthcare royalty partners designated activity company by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other large companies, companies in Region Area area or any other competitors across 12 key performance metrics.
sagard healthcare royalty partners designated activity company Ownership
SAGARD HEALTHCARE ROYALTY PARTNERS DESIGNATED ACTIVITY COMPANY group structure
Sagard Healthcare Royalty Partners Designated Activity Company has no subsidiary companies.
Ultimate parent company
SAGARD HEALTHCARE ROYALTY PARTNERS DESIGNATED ACTIVITY COMPANY
IE644718
SAGARD HEALTHCARE ROYALTY PARTNERS DESIGNATED ACTIVITY COMPANY Shareholders
The sole shareholder of Sagard Healthcare Royalty Partners Designated Activity Company is Maplesfs Trustees Ireland Limited.
maplesfs trustees ireland limited
100%
sagard healthcare royalty partners designated activity company directors
Sagard Healthcare Royalty Partners Designated Activity Company currently has 4 directors.
The longest serving directors include
KATE MACKEN (Feb 2019) and
MURRAY MACNAUGHTON (Mar 2019).
sagard healthcare royalty partners designated activity company Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to sagard healthcare royalty partners designated activity company. Currently there are 0 open charges and 1 have been satisfied in the past.
sagard healthcare royalty partners designated activity company Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SAGARD HEALTHCARE ROYALTY PARTNERS DESIGNATED ACTIVITY COMPANY. This can take several minutes, an email will notify you when this has completed.
sagard healthcare royalty partners designated activity companyCompanies House Filings - See Documents
